Yuri Hiramatsu

5PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersObstetrics and gynaecologyRheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 29, 2025
Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study.

Yuji Nozaki, Koichi Murata, Akira Onishi

|Oct 24, 2025
Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort study.

Yuri Hiramatsu, Takuya Kotani, Eri Nakamura

|Mar 20, 2025
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort.

Kohei Tsujimoto, Kosuke Ebina, Satomi Okamura

|Aug 19, 2023
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.

Kosuke Ebina, Yuki Etani, Yuichi Maeda

|Mar 10, 2022
Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.

Yoichi Nakayama, Ryu Watanabe, Kosaku Murakami

Pageof 1

Frequent Collaborators

4 joint publications

Motomu Hashimoto

4 joint publications

Wataru Yamamoto

4 joint publications

Yonsu Son

3 joint publications

Tadashi Okano